Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec 4;3(6):e001330.
doi: 10.1161/JAHA.113.001330.

Comparative effectiveness review of antiplatelet agents in peripheral artery disease

Kristine Schmit  1 , Rowena J Dolor  2 , W Schuyler Jones  3 , Sreekanth Vemulapalli  4 , Victor Hasselblad  5 , Sumeet Subherwal  4 , Brooke Heidenfelder  6 , Manesh R Patel  3
Affiliations
Review

Comparative effectiveness review of antiplatelet agents in peripheral artery disease

Kristine Schmit et al. J Am Heart Assoc. .
No abstract available

Keywords: antiplatelet therapy; aspirin; clopidogrel; peripheral artery disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Literature flow for inclusion/exclusion of antiplatelet studies. Adapted from Jones et al. CLI indicates critical limb ischemia; IC, intermittent claudication.
Figure 2.
Figure 2.
Results of aspirin versus placebo trials for all outcomes. Adapted from Jones et al. Asym indicates asymptomatic; CI, confidence interval; CV, cardiovascular; CVA, cerebrovascular accident; IC, intermittent claudication; MI, myocardial infarction; PAD, peripheral artery disease.
Figure 3.
Figure 3.
Results of clopidogrel versus aspirin for all outcomes in the PAD Subgroup of the CAPRIE study (1996). Adapted from Jones et al. CI indicates confidence interval; CV, cardiovascular; MI, myocardial infarction.
Figure 4.
Figure 4.
Results of dual antiplatelet therapy versus aspirin for all outcomes. Adapted from Jones et al. Asym indicates asymptomatic; CI, confidence interval; CLI, critical limb ischemia; CV, cardiovascular; IC, intermittent claudication; MI, myocardial infarction.
See this image and copyright information in PMC

References

    1. IOM (Institute of Medicine). Initial National Priorities for Comparative Effectiveness Research. 2009Washington, DC: The National Academies Press; http://www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPrioriti...
    1. Jones WS, Schmit KM, Vemulapalli S, Subherwal S, Patel MR, Hasselblad V, Heidenfelder BL, Chobot MM, Posey R, Wing L, Sanders GD, Dolor RJ. Treatment Strategies for Patients With Peripheral Artery Disease Comparative Effectiveness Review No. 118. (Prepared by the Duke Evidencex2010based Practice Center under Contract No. 290x20102007x201010066x2010I.) AHRQ Publication No. 3x2010EHC089x2010EF. 2013. Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed November 26, 2012. - PubMed
    1. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; Available at: www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and.... Accessed March 16, 2012.
    1. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008; 337:a1840. - PMC - PubMed
    1. Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010; 303:841-848. - PubMed

Publication types

MeSH terms

LinkOut - more resources